Stockholm - Delayed Quote SEK

S2Medical AB (publ) (S2M.ST)

0.0250
-0.0004
(-1.57%)
At close: May 23 at 5:29:58 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14,906
14,906
6,971
4,670.2020
7,699.7860
Cost of Revenue
766
766
1,934
-494.8460
602.7960
Gross Profit
14,140
14,140
5,037
5,165.0480
7,096.9900
Operating Expense
8,349
8,349
20,301
32,853.6460
26,932.8330
Operating Income
5,791
5,791
-15,264
-27,688.5980
-19,835.8430
Net Non Operating Interest Income Expense
-20
-20
-7,443
-1,767.8040
-243.4060
Pretax Income
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Diluted NI Available to Com Stockholders
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Basic EPS
0.27
0.01
-0.08
-0.69
-0.35
Diluted EPS
0.27
0.01
-0.08
-0.69
-0.35
Basic Average Shares
530,169.5340
559,858.1090
121,479.9880
119,523.7460
55,784.4500
Diluted Average Shares
530,169.5340
559,858.1090
121,479.9880
119,523.7460
55,784.4500
Total Operating Income as Reported
5,791
5,791
-15,264
-27,688.5980
-19,835.8430
Total Expenses
9,115
9,115
22,235
32,358.8000
27,535.6290
Net Income from Continuing & Discontinued Operation
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Normalized Income
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Interest Income
0
0
0
0
0
Interest Expense
20
20
7,443
1,767.8040
243.4060
Net Interest Income
-20
-20
-7,443
-1,767.8040
-243.4060
EBIT
5,791
5,791
-15,264
-27,688.5980
-19,835.8430
EBITDA
6,823
6,823
-13,530
-25,771.1930
-18,341.9550
Reconciled Cost of Revenue
766
766
1,934
-494.8460
602.7960
Reconciled Depreciation
1,032
1,032
1,734
1,917.4050
1,493.8880
Net Income from Continuing Operation Net Minority Interest
5,771
5,771
-22,707
-29,456.4020
-20,079.2490
Total Unusual Items Excluding Goodwill
--
--
0
0
0
Total Unusual Items
--
--
0
0
0
Normalized EBITDA
6,823
6,823
-13,530
-25,771.1930
-18,341.9550
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/28/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MEDIMI.ST Medimi AB (publ)
0.0034
-15.00%
 
IZAFE-B.ST iZafe Group AB (publ)
0.2560
-1.54%
 
AWM.WA Airway Medix S.A.
0.4125
-0.36%
 
CTEC.L ConvaTec Group PLC
285.40
+2.07%
 
ZJYL Jin Medical International Ltd.
0.7845
-1.20%
 
FEMY Femasys Inc.
1.0400
-1.89%
 
GCTK GlucoTrack, Inc.
0.1333
+0.38%
 
POAI Predictive Oncology Inc.
0.9761
-0.40%
 
STSS Sharps Technology, Inc.
4.0500
+2.79%
 
AKYA Akoya Biosciences, Inc.
1.2600
-3.08%